CNBCLean R·
Teva wins FDA approval for monthly schizophrenia injection Weltruza
Teva has received FDA approval for once monthly injectable schizophrenia drug Weltruza. The announcement sent Teva shares gaining in premarket.
Read at CNBC →
Teva has received FDA approval for once monthly injectable schizophrenia drug Weltruza. The announcement sent Teva shares gaining in premarket.
<iframe src="https://statesidedaily.com/embed/cluster/6021d6cc822130963508973ed1f14f5da318ec91" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Teva wins FDA approval for monthly schizophrenia injection Weltruza"></iframe>